Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.76 |
| ▸ | APAF1 | O14727 | 1/20 | 0.76 |
| ▸ | NPC1 | O15118 | 1/20 | 0.76 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | HTT | P42858 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.76 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.76 |
| ▸ | FDPS | P14324 | 17/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL232905 | 1.00 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Acetic Acid SCHEMBL1660890 | 1.00 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Acetic Acid SCHEMBL3143190 | 1.00 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Acetic Acid SCHEMBL2787360 | 1.00 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Acetic Acid SCHEMBL23004172 | 1.00 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Acetic Acid SCHEMBL23090491 | 1.00 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Acetic Acid SCHEMBL15170575 | 0.98 | MEN1 (0.73) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Acetic Acid SCHEMBL29142263 | 0.97 | MEN1 (0.71) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Oxalic Acid SCHEMBL29142274 | 0.96 | MEN1 (0.69) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Bicarbonate SCHEMBL23698460 | 0.94 | MEN1 (0.76) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12291506-B2 | Method for producing amidate compound, and amidate compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-05-06 | — | — | US | disclosed |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-17 | — | — | US | disclosed |
| CN-115052864-B | Method for producing carboxylate compound and method for producing amidate compound | 广荣化学株式会社 | 2025-02-28 | — | — | CN | disclosed |
| CN-118290346-A | Method for producing amide compound, and amide compound | 广荣化学株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-112703184-B | Method for producing amide compound, and amide compound | 广荣化学株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-117813334-A | Onium salt, blocking agent dissociation catalyst for blocking isocyanate, blocked isocyanate composition containing blocking agent dissociation catalyst, thermosetting resin composition, cured product, and method for producing same | 广荣化学株式会社 | 2024-04-02 | — | — | CN | disclosed |
| US-20230202988-A1 | AMIDATE COMPOUND, PRODUCTION METHOD THEREFOR, BLOCKING-AGENT DISSOCIATION CATALYST, AND THERMALLY CURABLE RESIN COMPOSITION | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230167229-A1 | BLOCKED ISOCYANATE COMPOSITION, HEAT-CURABLE RESIN COMPOSITION, CURED PRODUCT, PRODUCTION METHOD THEREFOR, AMIDATE COMPOUND, AND CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-06-01 | — | — | US | disclosed |
| US-11623971-B2 | Freestanding ion gel and method for preparing the same | Research & Business Foundation Sungkyunkwan University (KR) | 2023-04-11 | — | — | US | disclosed |
| US-20230095854-A1 | METHOD FOR PRODUCING CARBOXYLATE COMPOUND AND METHOD FOR PRODUCING AMIDATE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-03-30 | — | — | US | disclosed |
| CN-115397814-A | Amidate compound, method for producing same, blocking agent dissociation catalyst, and thermosetting resin composition | 广荣化学株式会社 | 2022-11-25 | — | — | CN | disclosed |
| CN-115052864-A | Process for producing carboxylate compound and process for producing amide compound | 广荣化学株式会社 | 2022-09-13 | — | — | CN | disclosed |
| US-20220048864-A1 | METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2022-02-17 | — | — | US | disclosed |
| EP-3858817-A1 | METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND | Koei Chemical Company, Limited (JP) | 2021-08-04 | — | — | EP | disclosed |
| CN-112703184-A | Process for producing amide compound, and amide compound | 广荣化学株式会社 | 2021-04-23 | — | — | CN | disclosed |
| US-20210054127-A1 | FREESTANDING ION GEL AND METHOD FOR PREPARING THE SAME | Research & Business Foundation Sungkyunkwan University (KR) | 2021-02-25 | — | — | US | disclosed |
| WO-2020067431-A1 | METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND | 広栄化学工業株式会社 | 2020-04-02 | — | — | WO | disclosed |
| US-20100081798-A1 | METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION | BASF SE (DE) | 2010-04-01 | — | — | US | disclosed |
| EP-2126104-A1 | METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION | BASF SE (DE) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008090156-A1 | METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION | BASF SE (DE) | 2008-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202988-A1 | AMIDATE COMPOUND, PRODUCTION METHOD THEREFOR, BLOCKING-AGENT DISSOCIATION CATALYST, AND THERMALLY CURABLE RESIN COMPOSITION | SETDB1, ARGLU1, ASH1L | MEN1 960/4885HSP90AA1 3086/4885KMT2A 1183/4885 |
| US-20230095854-A1 | METHOD FOR PRODUCING CARBOXYLATE COMPOUND AND METHOD FOR PRODUCING AMIDATE COMPOUND | CPS1, ASS1, ODC1 | MEN1 422/4885HSP90AA1 4502/4885KMT2A 2836/4885 |
| US-12291506-B2 | Method for producing amidate compound, and amidate compound | NAAA, NIT2, PAM | MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885 |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KDM2B, O60361, IDH3B | MEN1 1391/4885HSP90AA1 1476/4885KMT2A 322/4885 |
| US-20100081798-A1 | METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION | MGAM, LCT, SI | MEN1 2926/4885HSP90AA1 4744/4885KMT2A 2325/4885 |
| US-20220048864-A1 | METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND | NAAA, NIT2, PAM | MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.